Skip to main content

Moderna’s new COVID-19 vaccine for South African variant ready for human testing, company says

Moderna on Wednesday announced that the COVID-19 vaccine it recently developed to address a concerning new coronavirus variant first identified in South Africa is ready to be tested in people in clinical trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.